地图样萎缩继发AMD患者生活质量的决定因素
该前瞻性自然史研究纳入87例地图样萎缩继发AMD患者,纵向评估视功能相关生活质量(VRQoL),发现VRQoL composite评分受损(69.96),且与视功能和结构生物标志物相关,支持NEI VFQ-25的有效性。
要点
- 地图样萎缩继发AMD患者VRQoL composite评分显著受损,均值69.96。
- VRQoL与视功能及结构生物标志物存在横断面和纵向关联。
- NEI VFQ-25在GA患者中显示出良好的有效性。
核心结论
- 地图样萎缩继发AMD患者视功能相关生活质量显著受损。
- VRQoL与视功能和结构生物标志物的横断面及纵向关联支持NEI VFQ-25的有效性。
研究设计与样本
- 前瞻性、非干预性自然史研究(Directional Spread in Geographic-Atrophy,NCT02051998)。
- 纳入87例地图样萎缩继发AMD患者,平均年龄77.07±7.49岁。
- 采用线性混合效应模型分析VRQoL与候选决定因素的关联。
主要发现
- 基线时较好眼BCVA中位数(IQR)为0.3(0.51),较差眼为0.89(0.76)。
- 46%的患者为双眼非中心性GA,25.3%为单眼非中心性GA。
- VRQoL composite评分为69.96(24.03),显示受损。
临床怎么用
- 临床中可应用NEI VFQ-25评估GA患者的视功能相关生活质量。
- VRQoL与视功能及结构生物标志物相关,提示其在GA患者管理中的潜在价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To longitudinally evaluate vision-related quality of life (VRQoL) in geographic atrophy (GA) secondary to age-related macular degeneration (AMD) and define its relation to visual function and structural biomarkers. METHODS: Patients with GA secondary to AMD were recruited in the context of the prospective, non-interventional, natural-history Directional Spread in Geographic-Atrophy study (NCT02051998). Fundus autofluorescence and infrared reflectance images were semi-automatically annotated for GA. Linear mixed-effects models were applied to investigate the association of putative determinants with the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) VRQoL. RESULTS: A total of 87 patients with a mean age ± SD of 77.07 ± 7.49 years were included in the analysis. At baseline, median (IQR) best-corrected visual acuity (BCVA) was 0.3 (0.51) for the better eye and 0.89 (0.76) for the worse eye; 46% of the patients showed binocular and 25.3% monocular non-central GA. The VRQoL composite score was impaired: 69.96 (24.03). Sixty-six patients with a median of 2 (2) follow-up visits after 1.08 (0.78) years were examined longitudinally. CONCLUSIONS: Vision-related quality of life is significantly impaired in patients with GA secondary to AMD. The cross-sectional and longitudinal association of VRQoL with visual functional and structural biomarkers supports the validity of the NEI VFQ-25 VRQoL.
引用
- Künzel SH, Möller PT, Lindner M, et al. Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020. PMID: 32462198. doi:10.1167/iovs.61.5.63
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。